drugset / Trial / NCT05826574
A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The primary purpose of this study is to assess the effects of rifampin on the PK of brensocatib in Part 1 of the study and to assess the effects of esomeprazole on the PK of brensocatib in Part 2 of the study.
Timeline
- Start
- 2023-05-10
- Primary completion
- 2023-07-16
- Completion
- 2023-07-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brensocatib | Small molecule | — | Oral |
| Subject | Esomeprazole | Small molecule | 40 mg | Oral |
| Subject | Rifampin | Small molecule | 600 mg | Oral |
Indications
No indication recorded.